Program
Finasteride
Also written as “Finasteride 5 mg Tablet, single dose”, “minoxidil + finasteride” and “Finasteride 5 mg tablets”.
Its studies are mostly in Alopecia · Prostatic Hyperplasia · Acne Vulgaris, led by 9 companies.
Drug pageFinasteride: every studyMany companies study it; this page follows only the 17 they lead. All 49 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Dr. Reddy's Laboratoriesits history only | 40 open or running | phase 1since May 27, 2010 | May 27, 2010 | none ahead |
| Teva Pharmaceutical Industriesits history only | 40 open or running | phase 1since Feb 3, 2009 | Feb 3, 2009 | none ahead |
| Il-Yang Pharm.its history only | 21 open or running | phase 3since Oct 6, 2026 | Dec 11, 2025 | Aug 31, 2027phase 3 · NCT07870759 |
| Viatrisits history only | 20 open or running | phase 1since Mar 30, 2008 | Mar 30, 2008 | none ahead |
| Almirallits history only | 10 open or running | phase 1since Jun 1, 2016 | Jun 1, 2016 | none ahead |
| Beijing Dayspring Pharmaceutical Technologyits history only | 10 open or running | phase 2since Jul 1, 2025 | Jul 1, 2025 | none ahead |
| Eloracits history only | 10 open or running | phase 2since Jul 10, 2015 | Jul 10, 2015 | none ahead |
| HairDx | 10 open or running | phase 1since Jan 16, 2010 | Jan 16, 2010 | none ahead |
| Merckits history only | 10 open or running | phase 3since Feb 13, 2012 | Feb 13, 2012 | none ahead |
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of HairDx only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jan 16, 2010First study: phase 1 study in AlopeciaFirst studyNCT01052870 · 12 enrolled
TargetBeta
“Steroid 5-alpha-reductase 2 inhibitor”ChEMBL 37, by rule
Studies
The one study HairDx leads. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT01052870Alopecia | 1 | Completed | Dec 2009 | 12 |
How it is read
Names in the registry
- “Finasteride”, 6 entries
- “Finasteride 5 mg Tablet, single dose”, 3 entries
- “minoxidil + finasteride”, 2 entries
- “Finasteride 5 mg tablets”, 2 entries
- “Finasteride Tablets 5 mg”, 2 entries
Conditions, from the studies’ own filings
- Alopecia, 3 studies
- Prostatic Hyperplasia, 2 studies
- Acne Vulgaris, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.